The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients

Table 3

The GLUT-1 expression according to clinicopathological features.

	Average	Standard deviation	Minimum	Lower quartile	Median	Upper quartile	Maximum	𝑃
FIGO stage
IA	6.35	2.24	2	6	6	8	12	NS
IB	6.65	1.69	4	6	6	9	9
II	6.64	1.28	6	6	6	6	9
IIIA	6.00	0.00	6	6	6	6	6
IIIC	5.29	1.21	2	4	6	6	6
IVB	7.50	1.64	6	6	7.5	9	9
Grading
1	6.00	2.52	2	4	6	9	9	NS
2	6.31	1.62	2	6	6	6	12
3	6.33	1.78	2	6	6	6	9
Bokhman subtype
1	6.34	1.75	2	6	6	6	12	NS
2	6.14	1.61	2	6	6	6	9
Lymph node metastases
0	6.48	1.75	2	6	6	6	12	NS
1	5.74	1.48	2	6	6	6	9
Distant metastases
0	6.20	1.69	2	6	6	6	12	NS
1	7.50	1.64	6	6	7.5	9	9
Myometrial invasion >50%
0	6.16	1.90	2	6	6	6	12	NS
1	6.49	1.36	4	6	6	6	9
Cervical infiltration
0	6.35	2.07	2	6	6	8.5	12	NS
1	6.21	1.07	4	6	6	6	9
Infiltration of adnexa
0	6.25	1.77	2	6	6	6	12	NS
1	6.55	1.21	6	6	6	6	9
Risk of recurrence
Low	6.20	2.46	2	5	6	7.5	12	NS
Intermediate and high	6.31	1.45	2	6	6	6	9